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Objective: The evidence-based practice movement clearly defines the relevant
components of a good treatment. In the present article, we elaborate on how the active
involvement of patients within psychotherapy can and should be increased in order to
respect ethical considerations. Our arguments complement the requirements of
evidence-based practice, and are independent of the actual psychotherapeutic
treatment approach being used.
Method: Theoretical and ethical analysis.
Results: In order to respect patient autonomy, psychotherapy needs to be transparent
and honest when it comes to disclosing the relevant factors for promoting therapeutic
change. It has been argued that ethical informed consent needs to include empirically
supported patient information. In this paper we go one step further: we outline that fully
respecting ethical considerations in psychotherapeutic treatment necessarily calls for
acknowledging and strengthening the active role of patients in the course of
psychotherapy. Accordingly, patients need not only to be informed openly and
transparently about the planned treatment, the treatment rationale, and the expected
prognosis of improvement in the course of psychotherapy, but they also need to be
actively involved in the decision-making process and during the entire process of
psychotherapeutic treatment.
Conclusions: Our arguments support the tendency that can be observed in health care
in recent years towards more active patient involvement across different health-care
domains, but also in clinical research. This article offers an ethical perspective on the
question what defines a ‘good psychotherapy', which, hopefully, will help to leave behind
some of the ongoing psychotherapy debates and move the field forward.
Keywords: psychotherapy, patient-centered care, empirically supported treatment, evidence-based practice,
patient autonomyg June 2020 | Volume 11 | Article 4061
Gerger et al. Patients as Partners in PsychotherapyINTRODUCTION
Since Eysenck's provocative conclusion in 1952 that psychotherapy
doesn't facilitate recovery from mental disorders (1), it has been a
major goal of psychotherapy research to prove the efficacy and
effectiveness of psychotherapy. With the adoption of the criteria of
evidence-based medicine (2–4) to psychotherapy outcome research,
the proof of efficacy became necessary for a psychotherapeutic
treatment to be considered empirically supported and thus to be
recommended for clinical practice (5, 6). Within the evidence-based
practice framework, however, a broad perspective is taken into
account acknowledging that beyond the theory-driven ingredients
of the intervention, research evidence points to relevant
characteristics of the patient or client, as well as of the treatment
provider, and the interactive process of treatment as relevant aspects
(e.g., 7, 8). Following previous claims regarding the patient as being
a, if not the most important factor contributing to psychotherapy
effects (9–11), the present paper will focus on the role of patients
within the course of psychotherapeutic treatment.
Calls for more active patient involvement in psychotherapy
are not new, and have their origins within humanistic and
positive psychology, focusing on each person's potential for
growth (12). For instance, Rogers who developed the person-
centered psychotherapy approach, stated in 1963 “we could say
that in the optimum of therapy the person rightfully
experiences the most complete and absolute freedom” (13,
p.25). In 1994, Bergin and Garfield wrote that “clients are not
inert objects upon which techniques are administered…”, and
further, “as therapists have depended more upon the client's
resources, more change seems to occur” (14, p.825–826, as
cited in 15 p.84). In addition, literature on resilience points out
the potential of client- and patient-associated factors to be
related with self-directed change and self-healing, and to
contribute to health-improvements (16, 17). Interestingly,
Maslow's theory of human motivation (18) seems to have
anticipated these developments by highlighting the
importance of self-fulfillment and self-actualization as
forming the basis for personal functioning and resilience. As
a practical example of how the patient can be given the lead in
psychotherapy, a patient-led approach has been suggested and
evaluated, which gives the patient responsibility for the
planning and structuring of psychotherapy (19, 20).
Our paper will build on previous literature pointing out the
relevance of patient or client involvement in psychotherapy.Wewill
complement this line of research by adding an ethical perspective
and deducing that if transferring ethical considerations to
psychotherapy practice, actively involving patients in the entire
psychotherapeutic process is not only possible but also necessary
from an ethical point of view, although doing so, might be a
challenge in certain cases. From a practical point of view,
providing a clear and evidence-based guideline on how to realize
the goal of ethical patient involvement within practice is beyond the
scope of this article which rather aims at raising awareness on the
relevance of ethical considerations in psychotherapy. However, in
some instances we will provide examples on how the suggested goal
of ethical patient involvement may be translated or has been
translated to clinical practice.Frontiers in Psychiatry | www.frontiersin.org 2ETHICS IN PSYCHOTHERAPY
In medical ethics, the applied ethics approach of principlism
forms the basis for many ethical guidelines, and postulates four
ethical principles (21): first, respect for autonomy (self-
determination); second, beneficence (do good); third, non-
maleficence (do no harm); and fourth, justice (social
distribution of benefits and burdens). In dealing with ethical
questions, conflicts, and/or dilemmas, each of the four principles
needs to be specified and balanced, recognizing that there is no
hierarchical order of the four principles from the outset (21).
Not only in medicine in general but also in psychotherapy, the
applied ethics approach of principlism may be an attractive
framework for moral decision-making because it is
undogmatic, open with regard to any theory of normative
ethics, liberal, transparent, and rational. In recent years, an
increased emphasis on ethics in psychotherapy can be
observed, which may complement the available ethical codes of
conduct in several countries (e.g., 22, 23). Over the last five years,
the publication of textbooks for practitioners (e.g., 24, 25), of
scientific journal articles (e.g., 26, 27), of article collections and
special issues (e.g., 28, 29), and the publication of the “Oxford
Handbook of Psychotherapy Ethics” (30) reflect the increase in
interest and knowledge in this field.
In this context, ethical arguments have recently been raised to
call for adequate patient information in psychotherapy, based on
empirical evidence. Ethical patient information is required to
provide all the information that is necessary for a patient to make
an informed decision concerning a suggested treatment plan (6,
31–33). In a recent systematic review, Lamont-Mills and
colleagues summarized the evidence on the role of
confidentiality and informed consent in counselling and
psychotherapy (34). They concluded that within clinical
practice, psychotherapists apply standardized informed consent
templates but they also state that we know only little about the
actual adequacy of informed consent obtainment in
psychotherapy as well as on the patients' own understanding of
informed consent and confidentiality. We will argue in the
present article that despite the necessity to simply inform
patients about the suggested treatment, for instance by using
standardized informed consent templates, the patients should be
actively involved in the entire therapeutic process in an
individualized way. We will elaborate on how this can be done
and which aspects are to be considered when doing so.ETHICAL PATIENT INVOLVEMENT
Providing an Individualized, Plausible,
Comprehensive, and Honest Treatment
Rationale
From an ethical point of view, transparency in the conduct of
psychotherapy is essential and serves to respect and protect
patients' autonomy (31–33). To this effect, treatment rationales
need to be plausible and clear, but also compelling (35). It is
indispensable, however, that honesty is warranted, and thatJune 2020 | Volume 11 | Article 406
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need to be based on evidence-based and empirically supported
research findings (5, 31, 36, 37). Moreover, the therapist's
language must be adapted with respect to the patient's own
language (38), and the patient's individual context needs to be
considered. The provision of individualized honest and
transparent treatment rationales is key for assuring patient
autonomy in that they enable a patient to decide for or against
initiating psychotherapeutic treatment in an informed manner
(32, 33). In turn, a higher credibility of an initiated treatment, as
perceived by patients at an early stage of treatment, as well as
patients' outcome expectations have been shown to be
significantly associated with treatment outcomes (39, 40). Yet,
it is important to note that patient information does not need to
include the explanation of complex psychological theories if not
warranted. Research on the open and transparent administration
of placebo treatment for instance has demonstrated benefits of
the provision of rather short, yet compelling treatment rationales
even in the absence of an active treatment (41–43). However, the
integration of patient's individual views and perspectives within
the framework of evidence-based treatment might seem as a
contradiction. But recent research proposes to allow for more
variability and evidence-based therapist flexibility, for instance,
within the context-responsive psychotherapy integration
framework. The application of this framework in clinical
practice realizes personalization of psychotherapy by therapists'
responsiveness to patients' characteristic, for instance their
treatment-related beliefs (44). In summary we argue that the
process of informing a patient regarding a treatment rationale
within psychotherapy should actively consider the patient's own
perspectives in order to respect the patient's autonomy.
Defining the Outcome of
Psychotherapeutic Treatment Including
the Patient Perspective
To take the ethical principles of respect for autonomy and
beneficence seriously, patients should also be included in an
active manner in the process of defining the domain of outcome
of psychotherapeutic treatment. Strupp, Fox (45) were among
the first ones to highlight the relevance of the patients' own
perspective in outcome assessment in psychotherapy. Besides the
core symptoms as defined in diagnostic manuals (e.g. the
Diagnostic and Statistical Manual of Mental Disorders DSM-V
(46) or the International Statistical Classification of Diseases
ICD-10 (47), a range of additional health-related outcomes exist
which might be considered relevant as well (e.g., 48, 49).
Alternative treatment outcomes might encompass such aspects
as quality of life, well-being, self-efficacy, and social relationships,
among many more. For instance, meaning of life has been
described as being correlated with psychopathological
symptoms (50, 51), and as a possible alternative target
outcome of psychotherapy (52). In practice, the aim to include
patient's perspectives can be realized in diverse ways, including
for instance the use of multidimensional routine treatment
outcome packages (53), the assessment of personal target
complaints (54), but may also include the use of the “miracleFrontiers in Psychiatry | www.frontiersin.org 3question” or of “scaling questions” (55, 56). It might be argued,
that for many patients, particularly those who are ambivalent
about change, discussions about treatment goals and desired
outcomes of treatments might be challenging if not impossible.
De Shazer and Isebaert give an informative overview on how
respect for patient autonomy can be realized within inpatient
and outpatient psychotherapeutic treatment of alcohol abuse,
which has traditionally been described as being difficult to treat,
by focusing on “what patients want from therapy” (57, p.51).
Thus, in order to meet the ethical principles of respect for patient
autonomy and beneficence, the identification of the most
relevant health dimension to be improved in the course of a
psychotherapeutic treatment needs to actively include and
respect the patient's own perspective.
Discussing the Evidence Openly
With the Patient
In general, psychotherapy is required to have beneficial effects at
least on the core symptoms of a certain diagnosis in order to be
considered evidence-based. Unfortunately, due to the scarcity of
research on other outcome domains than symptom
improvement, we know only little about psychotherapy effects
on other outcome domains so-far. In order to respect the ethical
principle of respect for the patient autonomy, these lacks of
evidence should be discussed with patients. Further, the available
evidence on potentially occurring unwanted effects or side effects
in the course of psychotherapy is very limited (6, 58).
Nevertheless, in accordance with the ethical principles of
autonomy and of non-maleficence, the potential risks as well
as lacks of available evidence needs to be disclosed to patients
openly in order to allow for the patients to make an
informed decision.
Likewise, in accordance with the ethical principles of
beneficence and of non-maleficence, the influence of therapists,
proven to contribute significantly to treatment effects (59),
should be taken into account while discussing potential
treatment outcomes (60). Research has shown that not all
therapists are similarly effective (61–63). Yet, patients wish to
obtain information on their therapist's performance level (64).
Therefore, it is very important to discuss with a patient the
possibility that a mismatch between the patient and the therapist
may limit potentially beneficial treatment effects, in order to
avoid the patient to conclude that an unsuccessful course of
treatment was his or her own fault. Within the therapeutic
process, therapists could raise this issue occasionally, and offer
the pat ient the poss ib i l i ty to swap therapis ts , or
change treatment.
Discussing the Potential Course of
Symptom Improvement
Several meta-analyses have shown that short-term effects of
psychotherapeutic treatments may differ considerably from
long-term effects (65–68). From a clinical as well as from an
ethical and financial perspective, one could argue that a
treatment would need to contribute to long-lasting, sustainable
benefits in order to be recommended for clinical practice (69,June 2020 | Volume 11 | Article 406
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improvements may be considered relevant, and may
considerably impact well-being. For instance, in the context of
medically unexplained symptoms, it has been argued that given
the high personal burden associated with the mostly chronic
course of symptoms without the hope for complete recovery,
even short-term symptom relief might be considered as highly
relevant by individual patients (67). In addition, therapists might
argue that short-term deteriorations of symptoms or well-being
may be part of the therapeutic process, which eventually lead to
long-term improvements. For instance, crying during
treatment sessions has been described as relieving distress and
arousal, but can also be perceived as stressful in itself, and as
contributing to the experience of increasing arousal (71). In this
context, however, the ethical principle of doing no harm
(nonmaleficence), for example the danger of introducing
negative expectations, and increasing the risk for the
occurrence of nocebo effects needs some attention (72). It
could further be argued, that talking about potentially
occurring symptom deteriorations might decrease patients'
commitment to treatment and the therapeutic relationship.
Previous research, however, identified potential and diverse
ways how to deal with such difficult situations within
psychotherapy (57, 73, 74). It is important however to respect
patients' autonomy by allowing the patients an informed
decision whether or not to adhere to a suggested treatment
plan. Accordingly, the discussion of the potential course of
symptoms over time, which may include temporal symptom
deteriorations or possible discrepancies between expected short-
and long-term effects of psychotherapy, requires a particularly
sensitive and individualized process, which necessarily takes into
consideration a patient's previous experience, expectations, and
other patient-related characteristics.
Considering Patients’ Previous Experiences
In the course of ethically sound psychotherapy, exploring and
discussing patients' previous treatment experiences as well as
their subjective illness narratives (i.e. their own understanding
regarding how a certain illness is perceived, understood and
managed; 75) seems most relevant. Besides exploring patients'
previous treatment experiences, it is also relevant to explore what
patients themselves have been doing in the past in order to deal
with difficulties and crises in their lives, as well as pointing out
previous successes and achievements in handling previous
problems (56). Such explorations may give important hints
regarding patients' strengths and resources, and can contribute
to creating awareness and positive expectations while
strengthening the patients' own capacity to cope with
problems. In this sense, psychotherapy can be described as
contributing to transforming non-adaptive narratives into
adaptive ones (76). Thus, “psychotherapy is not simply the
vehicle for the delivery of psychological ingredients but is,
rather, a highly entwined system that uses language to
construct or, better said, reconstruct the patient's interpretation
of the world.” (77, p. 862). In practice, acknowledging patients
previous experiences can be done for instance by respondingFrontiers in Psychiatry | www.frontiersin.org 4individually to patients unique characteristics and emerging
scenarios (44), or by the exploration of so-called exceptions of
the problem (57).
Monitoring Treatment Progress
In shifting the focus towards the patient's perspective in
clinical research, patient-reported outcomes measures
(PROMs) were originally applied in clinical research in order
to quantitatively assess health outcomes from the patient's
perspective (78, 79). Meanwhile, however, they are
increasingly used in clinical practice to monitor and improve
health care for individual patients (80). Also in the specific
context of psychotherapy feedback systems have been
introduced (81, 82), which can be used to inform the
therapist about the actual course of a particular patient, and
may facilitate personalized planning and adapting of processes
within psychotherapy. For example, the application of the
routine outcome monitoring has been shown to be superior
to “clinical judgment in predicting patients who are on or off
track for treatment success” (82, p.459). Electronic feedback
systems just as the use of PROMs in clinical practice are
assumed to help improving the communication between
patients and clinicians, to foster a shared decision-making
process, and to develop and monitor personalized care plans
(83). However, they are not to replace the necessary exchange
between a clinical psychologist and the patient regarding the
patient's idiosyncratic perceptions of and attitudes towards the
course of treatment.CONCLUSIONS
During the last decades, psychotherapy research just as other
areas of mental health care research have largely focused on the
one hand on the identification of clear-cut definitions of mental
disorders with several revisions of the defining criteria over the
years (84–86), and on the other hand on the identification of
treatments that are specifically tailored to a diagnosis and which
were assumed to help eliminate the defining symptoms of a
diagnosis better than other more generic treatments (49, 87).
This dominating view made psychotherapy research endeavors
initially focus on proving the efficacy of psychotherapeutic
treatments. Over the years, the focus slightly moved towards
more naturalistic investigations of the effectiveness of treatments,
and in recent years, the efficiency of psychotherapy gained more
research interest, and an increase in publications on the cost-
effectiveness of psychotherapeutic treatments can be observed
(see e.g., 88–92).
In addition to efficacy, effectiveness and efficiency, however,
ethical considerations are most relevant when talking about
criteria of a ‘good' psychotherapy. We have argued that
treatment recommendations, which respect the ethical principles
of respect for autonomy, beneficence, non-maleficence, and justice,
reflect an individualized patient-centered process that should
incorporate the relative importance of individual patient's
history, values and needs.June 2020 | Volume 11 | Article 406
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We showed that an active involvement of patients is most
relevant when including ethical principles in psychotherapy
decision-making and practice. In this understanding, based on
the ethical principles of respect for autonomy and beneficence,
patients are to be seen as partners in clinical practice. In
addition, it has been argued recently that patients' perspectives
should be included in clinical research as well, for instance in
study design and governance (93, 94), in order to increase the
relevance of research findings for the patients and the actual
clinical practice outside of the academic setting. These claims
are nicely summarized in The BMJ's patient partnership
strategy (95), as well as in the statements published by the
Patient-Centered Outcomes Research Institute in the US (96,
97), as well as the National Institute for Health Research in the
UK (98).
The addition of ethical considerations to the debate strengthens
previous calls for shifting the focus from the treatment itself towards
other relevant aspects of psychotherapy (99, 100). In particular,
patients themselves as active agents within psychotherapy need
more attention, including their idiosyncratic experiences with
psychotherapy, as well as their perspectives on health and illness
(i.e. their illness and health narratives), their moral and normative
values, but also their financial and time-wise investments when
initiating psychotherapy (10, 37, 99, 101).
Our call for more patient involvement in the course of
psychotherapy is not new. In fact, some psychotherapeutic
approaches exist which are not based on theoretical
assumptions about the etiology of mental problems or
disorders, but which focus more on the idiosyncratic process
within psychotherapy. For instance, in solution focused brief
therapy the patient is seen as the expert of therapeutic change
rather than the therapist (102). Likewise, humanistic
approaches, such as person-centered psychotherapy in
general and, in particular, motivational interviewing, rely on
establishing and safeguarding of a therapeutic alliance to allow
and foster change. They have a strong focus on the processes of
change rather than on etiological models or the adherences to
protocols and manuals (103, 104). The three outlined
psychotherapeutic approaches have in common that patients'
views, experiences, values, and needs are actively involved
throughout the whole course of treatment—an expression of
the ethical principle of respect for autonomy, while the
therapist supports and guides rather than directs the
therapeutic process.
One Size Does Not Fit All
We conclude that the ethical principles of patient autonomy,
beneficence, non-maleficence and justice can best be respected
within an individualized and patient-centered process within
psychotherapeutic treatment. In this context the principles
described in person-centered psychotherapy (104) seem to be of
high relevance just as the processes described for instance in the
context of motivational interviewing (103), or in the therapist's
attitude of ‘not-knowing' in solution focused brief therapy (56, 102).Frontiers in Psychiatry | www.frontiersin.org 5We have argued that throughout the course of psychotherapy,
therapists need to remain in exchange with the patient regarding
the process of change during the course or after finishing
psychotherapy. This exchange may include discussions about
first, multiple dimensions of potential treatment outcomes (i.e.
not only focusing on symptom improvement but on a broader
range of health-related outcomes), second potential symptom
worsening or otherwise occurring adverse events, third, the long-
term perspectives of expected treatment effects, and fourth, the
costs of a psychotherapeutic treatment, financially but also time-
wise. All four of them may differ considerably between
individuals with respect to their actual content and the
relevance of one aspect compared to the others. This exchange
between patient and therapist should be tailored to individual
patients and should be guided by their previous experiences,
their individual illness narratives, their values, and needs.
It is important to keep in mind, however, that comprehensive
patient information also bears potential risks. Just as in medical
treatment, where unwanted events can be elicited by
emphasizing them (e.g., 105, 106), the occurrence of so-called
nocebo effects has also been discussed in the context of
psychotherapy (72, 107–109). From an ethical perspective,
risks should neither be exaggerated nor be concealed by a
practitioner (110). In order to respect ethical principles, and in
order to avoid the occurrence of nocebo-effects (maleficence), in
the case of doubt, patients should explicitly be asked whether
they care for knowing all details regarding potential risks that
may be associated with initiating psychotherapeutic treatment
thereby meeting the ethical principle of respect for the
patient's autonomy.
Following our arguments there is probably not one
recommendable ‘good' or ‘best' psychotherapy. Rather, the
evaluation of certain psychotherapeutic treatments as a ‘good'
psychotherapy for a certain patient always constitutes an
individual decision (99), and may thus differ across
individuals depending for instance on their backgrounds,
clinical conditions, personal values, and their illness and
health narratives. The addition of the ethical perspective to
the evaluation of psychotherapeutic treatments may therefore
be seen as a key element which shifts the focus from a
treatment itself (i.e. its efficacy, effectiveness and efficiency)
towards the patient, and thus necessarily strengthens the
patient's active role within psychotherapy.AUTHOR CONTRIBUTIONS
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